BMRN - BIOMARIN PHARMACEUTICAL INC
60.57
0.140 0.231%
Share volume: 2,245,618
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$60.43
0.14
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-26-2024 | 08-05-2024 | 10-31-2024 | 02-24-2025 | 05-02-2025 | 08-05-2025 | 10-28-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 6.873 B | 7.067 B | 6.851 B | 6.989 B | 7.147 B | 7.456 B | 7.615 B | 7.594 B | |
| Current Assets | 2.985 B | 3.260 B | 3.057 B | 3.232 B | 3.468 B | 3.805 B | 3.855 B | 3.953 B | |
| Inventories | 1.138 B | 1.184 B | 1.179 B | 1.233 B | 1.275 B | 1.340 B | 1.382 B | 1.299 B | |
| Other Current Assets | 163.287 M | 160.426 M | 169.260 M | 201.533 M | 181.545 M | 177.183 M | 204.265 M | 185.784 M | |
| Short Term Investments | 299.584 M | 252.201 M | 254.996 M | 194.864 M | 223.532 M | 218.309 M | 227.731 M | 248.930 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 746.996 M | 972.150 M | 675.448 M | 942.842 M | 1.049 B | 1.214 B | 1.250 B | 1.312 B | |
| Total Non-current Assets | 620.551 M | 557.083 M | 561.985 M | 521.238 M | 506.724 M | 508.592 M | 512.937 M | 492.242 M | |
| Property Plant Equipment | 1.060 B | 1.053 B | 1.045 B | 1.043 B | 1.033 B | 1.030 B | 1.038 B | 952.508 M | |
| Other Assets | 2.827 B | 2.755 B | 2.749 B | 2.713 B | 2.646 B | 2.621 B | 2.722 B | 2.688 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 6.873 B | 7.067 B | 6.851 B | 6.989 B | 7.147 B | 7.456 B | 7.615 B | 7.594 B | |
| Total liabilities | 1.799 B | 1.781 B | 1.438 B | 1.331 B | 1.354 B | 1.429 B | 1.558 B | 1.507 B | |
| Total current liabilities | 1.088 B | 1.067 B | 715.658 M | 606.988 M | 628.213 M | 684.247 M | 798.438 M | 759.031 M | |
| Accounts Payable | 593.543 M | 572.500 M | 715.658 M | 606.988 M | 628.213 M | 684.247 M | 798.438 M | 759.031 M | |
| Other liabilities | 117.352 M | 119.369 M | 127.514 M | 128.824 M | 129.685 M | 148.819 M | 163.056 M | 150.816 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 593.605 M | 594.116 M | 594.627 M | 595.138 M | 595.650 M | 596.162 M | 596.663 M | 597.176 M | |
| Other liabilities | 117.352 M | 119.369 M | 127.514 M | 128.824 M | 129.685 M | 148.819 M | 163.056 M | 150.816 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.074 B | 5.286 B | 5.413 B | 5.658 B | 5.793 B | 6.027 B | 6.057 B | 6.087 B | |
| Common stock | 5.619 B | 5.697 B | 5.740 B | 5.802 B | 5.794 B | 5.852 B | 5.901 B | 5.957 B | |
| Retained earnings | -532.892 M | -425.718 M | -319.638 M | -194.695 M | -9.009 M | 231.523 M | 200.779 M | 154.206 M |